| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 2973141 | The Journal of Heart and Lung Transplantation | 2006 | 4 Pages |
Abstract
In our experience, the Levitronix Centrimag seems to be safe and effective in the treatment of primary graft failure, achieving effective circulatory support and ventricular off-loading. We propose its use in isolated or biventricular graft failure either as bridge to re-transplant or as a bridge to recovery.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Gianluca MD, Mario PhD, FRCS, John R. FRCS, Gilles FRCS, Asghar FRCS, Emma J. MRCP, PhD,